JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 102 filers reported holding JOUNCE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $11,454 | -97.5% | 10,319 | -94.7% | 0.00% | – |
| Q3 2022 | $452,000 | -21.5% | 193,496 | +1.7% | 0.00% | – |
| Q2 2022 | $576,000 | +689.0% | 190,173 | +1666.3% | 0.00% | – |
| Q1 2022 | $73,000 | -15.1% | 10,767 | +5.7% | 0.00% | – |
| Q4 2021 | $86,000 | -7.5% | 10,188 | -18.6% | 0.00% | – |
| Q3 2021 | $93,000 | +22.4% | 12,518 | +12.3% | 0.00% | – |
| Q2 2021 | $76,000 | -14.6% | 11,148 | -12.9% | 0.00% | – |
| Q4 2020 | $89,000 | -87.7% | 12,792 | -85.6% | 0.00% | – |
| Q3 2020 | $726,000 | -54.3% | 88,912 | -61.4% | 0.00% | -100.0% |
| Q2 2020 | $1,589,000 | +55.3% | 230,292 | +96.5% | 0.00% | – |
| Q4 2019 | $1,023,000 | – | 117,169 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 572,829 | $1,340,000 | 100.00% |
| TRV GP III, LLC | 1,148,780 | $2,688,000 | 1.17% |
| COWEN AND COMPANY, LLC | 3,647,430 | $8,535,000 | 0.82% |
| Octagon Capital Advisors LP | 1,400,000 | $3,276,000 | 0.56% |
| Deep Track Capital, LP | 4,259,653 | $9,968,000 | 0.46% |
| PFM Health Sciences, LP | 4,094,488 | $9,581,000 | 0.35% |
| RTW INVESTMENTS, LP | 5,106,341 | $11,949,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $645,000 | 0.24% |
| Monarch Partners Asset Management LLC | 228,370 | $534,000 | 0.16% |
| Orbimed Advisors | 2,928,900 | $6,854,000 | 0.13% |